FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

840405005: Tazemetostat (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3901912011 Tazemetostat (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3901913018 Tazemetostat en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3901912011 Tazemetostat (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3901913018 Tazemetostat en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tazemetostat Is a Enzyme inhibitor false Inferred relationship Existential restriction modifier (core metadata concept)
Tazemetostat Is a Substance with methyltransferase inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Tazemetostat Has disposition Methyltransferase inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Tazemetostat Is a Antineoplastic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Tazemetostat Is a Substance with benzamide structure (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Tazemetostat only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tazemetostat Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing tazemetostat in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tazemetostat Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing tazemetostat (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tazemetostat Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only tazemetostat in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Tazemetostat Inferred relationship Existential restriction modifier (core metadata concept) 1
Tazemetostat (as tazemetostat hydrobromide) 200 mg oral tablet Has basis of strength substance (attribute) True Tazemetostat Inferred relationship Existential restriction modifier (core metadata concept) 1
Tazemetostat hydrobromide Is modification of (attribute) True Tazemetostat Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start